Organisation paid for research Program year 2025 Source: CMS Open Payments

Mra Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$982,045

18 payments

Through program year 2025, Mra Clinical Research is reported as receiving $982,045 in research payments, across 18 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$3,354	2
2024	Research	$2,663	2
2023	Research	$114,983	4
2022	Research	$117,780	5
2020	Research	$181,117	4
2019	Research	$562,148	1

Breakdown

Who paid Research payments · program years 2019–2025

E.R. Squibb & Sons, L.L.C. $562,148 1 payment
Upsher-Smith Laboratories LLC $219,069 11 payments
AMAG Pharmaceuticals, Inc. $200,828 6 payments

Studies the money was for Research payments · program years 2019–2025

A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes $562,148 1 payment
Vogelxo(R) Abpm Study in Hypogandal Men $158,217 3 payments
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ciraparantag for Reversal of Anticoagulation in Healthy Adults $138,267 4 payments
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ciraparantag for Reversal of Anticoagulation in Healthy Adults $62,561 2 payments
Vogelxo(R) Abpm Study in Hypogandal Men $51,572 3 payments
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 4 Study to Evaluate the Efficacy and Safety of Qudexy(R) XR in the Prevention of Migraine in Children 6 to 11 Years of Age $5,926 3 payments
P255-501 $3,354 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.